Skip to main content

Urology · UK

Sacral neuromodulation - a device decision, made properly.

A tiny implanted pacemaker for the S3 nerve - for refractory overactive bladder, non‑obstructive retention and faecal incontinence. Axonics, InterStim Micro and InterStim X compared side‑by‑side, with a proper test phase before anything permanent goes in.

A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What private sacral neuromodulation costs in the UK.

Indicative ranges across UK functional urology units.

In short

£18,500–£26,000, home the same day.

Procedure or device Indicative range
Peripheral nerve evaluation (PNE) test only £2,600–£3,800
Stage 1 tined lead trial £5,500–£7,800
Full SNM implant - Axonics rechargeable £20,500–£26,000
Full SNM implant - InterStim Micro (rechargeable) £19,000–£24,500
Full SNM implant - InterStim X (recharge‑free) £18,500–£23,000
Generator replacement (end of battery life) £8,000–£12,500
Percutaneous tibial nerve stimulation (PTNS) course £1,400–£2,200
Urogynaecology consultation only £280–£475

Prices vary by hospital, by the implanting consultant, and by device family - rechargeable systems are slightly costlier upfront and last longer. On the NHS, sacral neuromodulation is commissioned for refractory OAB and faecal incontinence in specialist centres, with waits often measured in months rather than weeks.

The problem

The right device, the right test, and a plan you can live with for fifteen years.

Neuromodulation is where the manufacturer often chooses for the patient - because a clinic stocks one brand, or a surgeon has a preference. We reverse that.

  • Match the device to your life

    Rechargeable versus recharge‑free is a lifestyle question - hand dexterity, memory, comfort with weekly routines. It should be your call, not the clinic’s.

  • Test before you commit

    A PNE or staged trial with a 50% threshold means you never carry a permanent implant that does not work for you.

  • Protect future MRIs

    If you have MS, cancer surveillance or spinal disease, your device must be full‑body MR‑conditional.

When it helps

When sacral neuromodulation is the right step.

The situations we see most, plus the one red flag that means spinal cord assessment urgently rather than a routine referral.

  • Refractory urgency incontinence

    Wet urgency that has not settled on two classes of bladder medication, or where anticholinergic side effects (dry mouth, cognitive fog) make them intolerable.

  • Overactive bladder - dry variant

    Frequency and urgency without leakage, unresponsive to lifestyle change, mirabegron and pelvic floor training. Botox has failed or is not wanted.

  • Non‑obstructive urinary retention

    Poor bladder emptying with no anatomical blockage - Fowler’s syndrome in younger women, idiopathic in older adults. SNM often restores voiding.

  • Faecal incontinence

    Passive or urge faecal incontinence that has not responded to fibre, loperamide, biofeedback and pelvic floor physiotherapy - SNM is licensed for this indication.

  • Post‑Botox non‑responder

    Detrusor Botox has failed, is wearing off too quickly, or has caused clean intermittent self‑catheterisation you cannot tolerate - SNM is the next line.

  • MRI‑dependent patient

    You have MS, cancer surveillance, or spinal disease and need repeat full‑body 1.5T or 3T MRI. Newer SNM systems are MR‑conditional whole‑body - device choice matters.

  • Chronic pelvic pain syndromes

    Off‑label but sometimes useful for bladder pain syndrome and pudendal neuralgia where standard care has failed - always after a careful trial.

  • Red flag: new neurological signs

    Saddle numbness, new leg weakness or acute retention with back pain is cauda equina until proven otherwise - same‑day MRI and spinal opinion, not a routine SNM referral.

Device and pathway options

Three implants, two test phases, and two non‑implant alternatives.

Sacral neuromodulation is a category, not a product. Here is the honest side‑by‑side - including the non‑implant options that suit many patients better.

  • Axonics R20 (rechargeable)

    15‑year rechargeable, small footprint, whole‑body 1.5T/3T MR‑conditional. Weekly home charge (about an hour). The go‑to for patients under 60 who value long service life.

  • InterStim Micro (Medtronic)

    Rechargeable, ~15‑year battery, MR‑conditional. Similar footprint to Axonics. Established manufacturer, mature programming platform - a solid alternative.

  • InterStim X (recharge‑free)

    Primary‑cell battery, no charging ever. Lasts 10–15 years depending on settings. Ideal for patients who do not want a nightly or weekly routine - often older adults.

  • PNE test (office, awake)

    A temporary wire placed under local anaesthetic through the sacral foramen. 5–7 days on an external stimulator, diary kept. Cheap, low commitment, but less predictive.

  • Staged tined‑lead trial

    The permanent lead placed under X‑ray, connected to an external stimulator for two weeks. More accurate than PNE but a two‑stage anaesthetic exposure.

  • Percutaneous tibial (PTNS)

    Weekly ankle‑needle stimulation for 12 weeks. Non‑implantable, so no MRI concerns. About 55% of patients get 50%+ improvement - a reasonable first step.

  • Implantable tibial (eCoin, Revi)

    A newer coin‑sized tibial implant with monthly clinic sessions or closed‑loop home use. Growing UK availability for OAB patients who want no sacral implant.

  • Bladder Botox as an alternative

    Detrusor onabotulinumtoxinA every 6–9 months. Effective but time‑limited, and 6–10% need self‑catheterisation. Some patients prefer this to a permanent device.

Safety and living with the device

What to expect afterwards - honestly.

SNM is a mature, well‑tolerated therapy. The things worth planning are lead position, device family and the long game of reprogramming and battery life.

  • Lead migration is the main early issue

    Around 3–5% of leads shift enough to lose therapy in the first six months. Revision under X‑ray is straightforward; tined leads have made this much less common than a decade ago.

  • Infection - 3–5% at the pocket

    The upper buttock pocket can become infected within the first six weeks. Antibiotic prophylaxis, wound care and prompt review keep this rare. Explant is only needed in a minority.

  • Pain at the implant site

    A dull ache at the generator pocket for 4–6 weeks is normal. Persistent pain, or a stinging sensation when the device is on, usually settles with a reprogramming session.

  • Loss of response over time

    10–20% of patients see gradual efficacy loss over 3–5 years. Reprogramming, lead revision, or a battery/device swap often restores response - it is not usually the end of the road.

  • MRI compatibility depends on the device

    Modern InterStim X and Axonics systems are full‑body MR‑conditional at 1.5T and 3T. Older InterStim II implants are head‑only conditional. Choose the device with your future scan needs in mind.

  • Battery life and replacement

    Rechargeable devices: 15 years, then generator swap. Primary‑cell (recharge‑free): typically 10–15 years. Replacement is a 30‑minute day‑case under local - the lead usually stays.

  • Diathermy, defibrillation and pacemakers

    Monopolar diathermy at future surgery, external defibrillation and MRI outside the device envelope need care. You will carry a patient ID card and the surgical team will be briefed.

  • Pregnancy

    The device is usually turned off during pregnancy - data are limited. If you are planning a family within a few years, mention it early so we build it into the device choice.

  • Red flags after implant

    Spreading redness, discharge, fever, sudden severe leg pain or a shock‑like sensation with movement needs same‑day review, not a routine call.

Reading your implant note

Your operation note in four parts. Read the last one first.

Whichever device went in, the note the implanting consultant sends you keeps to the same shape.

A UK consultant urologist reviewing a patient’s SNM implant notes

A quiet reminder

Device language is precise and can read coldly - ask your care team to explain anything that is unclear.

Ask your care team to explain anything that is unclear.

  1. 01 Header

    Indication, device and lead position

    Why SNM was chosen, which manufacturer and model went in, and which sacral foramen (usually S3) was used for the tined lead.

  2. 02 Technique

    Fluoroscopy, motor responses, thresholds

    Bellows contraction of the pelvic floor and great‑toe plantarflexion at the four lead contacts - the numbers that tell your device nurse where to start programming.

  3. 03 Findings

    Test‑phase response and diary data

    Percentage improvement in leakage episodes, urgency episodes, voided volumes or bowel accidents versus baseline. 50% is the accepted threshold to proceed.

  4. 04 Impression

    Programming plan, charging routine, follow‑up

    Read this first: your starting programme, how to use the patient controller, when to charge if applicable, and when your next reprogramming visit is booked.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Sacral neuromodulation is often covered by UK private insurers when NICE eligibility is met and conservative therapy has failed. Device implants may need pre‑authorisation and a documented test‑phase response.

Frequently asked

Everything we get asked about sacral neuromodulation.

Quick answers on device choice, test phase, MRI, cost and recovery.

  • What is sacral neuromodulation, in plain English?

    A small pacemaker‑style device implanted in the upper buttock, wired to the S3 sacral nerve, that delivers gentle electrical pulses to reset the nerve traffic between the bladder or bowel and the brain. It does not paralyse the nerve - it modulates it - which is why symptoms can improve without changing bladder capacity or sensation dramatically.

  • How is sacral neuromodulation different from PTNS or tibial stimulation?

    PTNS (percutaneous tibial nerve stimulation) is a needle in your ankle, weekly for 12 weeks, no implant. Sacral neuromodulation is a permanent implant near the tailbone that runs 24/7 in the background. Response rates are broadly similar in the short term (50–70%), but SNM keeps working long‑term without weekly visits, and covers faecal incontinence and non‑obstructive retention, which PTNS does not.

  • Axonics, InterStim Micro or InterStim X - how do I choose?

    Axonics and InterStim Micro are rechargeable with a ~15‑year service life - best if you are younger, comfortable with a weekly hour on the charger and value the smaller footprint. InterStim X is recharge‑free and lasts 10–15 years - best if you never want to think about charging, particularly if you are older or have dexterity issues. All three are MR‑conditional whole‑body at 1.5T and 3T. Your MRI needs, hand function and lifestyle drive the choice, not marketing.

  • Do I have to try a test phase first?

    Yes, and you should want to. A percutaneous nerve evaluation over 5–7 days, or a two‑week staged tined‑lead trial, tells you and us whether the therapy will actually help. The 50% improvement threshold is not marketing - it is the point at which permanent implantation reliably pays off. About 60–70% of properly selected patients pass this test.

  • Will it hurt, and can I feel it working?

    Most patients feel a gentle tingle or fluttering in the perineum or vaginal area when the device is first turned on. The threshold is then set just below what you can feel, so day‑to‑day you are usually unaware of it. The implant site itself aches for 4–6 weeks and then settles.

  • How much does a private SNM implant cost in the UK?

    A PNE test alone runs £2,600–£3,800. A staged tined‑lead trial is £5,500–£7,800. A full implant sits at £18,500–£26,000 depending on the device family, with rechargeable systems slightly costlier upfront but offering longer service. Generator replacements at end of battery life are £8,000–£12,500.